Medtronic's Itamar seeks partners, U.S. listing; Check-Cap to raise $27M;

@FierceMedDev: HTG Molecular Diagnostics mulls $60M IPO for next-gen profiling technology. FierceDiagnostics story | Follow @FierceMedDev

@EmilyWFierce: Aethlon Medical snagged FDA approval for clinical trial of bio-filtration device to treat Ebola. Release | Follow @EmilyWFierce

> Bloomberg reports that sleep apnea and heart diagnostics company Itamar Medical is seeking partners and may list in the U.S. The company is already partnered with and backed by Medtronic ($MDT), which is its largest shareholder. Report

> Check-Cap hopes to raise $27 million in an IPO and a private placement. The Israeli-backed company has an ingestible low-dose x-ray capsule used for colon cancer screening. Story

> Stryker ($SYK) has acquired the assets of privately held CHG Hospital Beds, which sells low-height hospital beds and accessories, for an undisclosed amount. Release

> Symmetry Surgical has partnered with neoSurgical to distribute its neoClose Trocar Port Closure System in the U.S. Release

Biotech News

@FierceBiotech: Aduro bags $51M for its 'breakthrough' cancer combo. Story | Follow @FierceBiotech

@JohnCFierce: Big round of deals today augurs well for new partnerships/ M&A in 2015. #JPM15 will be abuzz with deal talk (not unusual). #biotech | Follow @JohnCFierce

@DamianFierce: $AMGN buys into CAR-T with $KITE partnership. Release | Follow @DamianFierce

> Pfizer continues deal spree with Redvax CMV vaccine buyout. Report

> Novartis rolls toward FDA nod with a copy of Amgen's Neupogen. Article

> Bristol-Myers to collaborate with Calibr on fibrosis drugs. Item

Pharma News

@FiercePharma: Pfizer's growth spurt continues with pickup of Switzerland's Redvax. FierceVaccines Story | Follow @FiercePharma

@CarlyHFierce: Indivior CEO looks beyond 2015 after troubled Reckitt pharma unit's spinoff. Story | Follow @CarlyHFierce

> Move over, Big Pharma: Smaller biopharma's execs are bringing home more bacon. Article

> Pfizer pads growing vaccines unit with CMV pickup. Item

> Merck poised for early Keytruda launch in lung cancer, analyst says. Article

Biotech IT News

> Scripps director: Validation needed to unlock the potential of wearables. Item

> NHS England picks 100,000 Genomes Project sites ahead of February start date. Article

> Analytics and Big Data investments spur bumper year for digital health funding. Story

> FDA outlines industry-focused ambitions as Mini-Sentinel graduates. More

> Roche buys Bina to add informatics piece to its genomics resurgence. News

CRO News

> Evotec teams up with Ohio State on a new cancer drug. Story

> WuXi goes mobile with a chemistry app. News

> GVK feels the sting after data scandal. More

> Covance could face fines over animal deaths. Story

> PPD bets on Japan with new joint venture. Article

Animal Health News

> Lilly closes Novartis deal, creating second-largest animal health giant. News

> FDA trusts vets to curb antibiotic use, but are ties to drug companies too tight? More

> High debt, low starting salaries plague new veterinarians. Item

> Colorado State nabs record $42.5M gift for translational research institute. Story

> Putney CEO Hoffman sets sights high for 'largest pipeline' in animal health. Article

Suggested Articles

Qiagen launched a one-stop shop compiling publicly available genomic data, scientific literature and phenotypic information on potential superbugs.

Adaptive Biotechnologies is planning a $200 million IPO to help power its sequencing tests aimed at the body’s immune system and related therapies.

Abbott’s new diabetes test provides A1c results in three minutes, allowing clinicians to develop care plans within a single office visit.